Lonza Group AG
LONN
Rang in aandelen
#449
Lonza Group AG, together with its subsidiaries, operates as a contract... Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing; and operates mammalian and drug product platforms. Its Advanced Synthesis segment manufactures antibody-drug conjugates (ADCs) and other bioconjugates, small molecules, and highly potent active pharmaceutical ingredients; and operates small molecules and bioconjugates platforms. The Specialized Modalities segment operates various technologies, such as spanning cell & gene, microbial, bioscience, and mRNA. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.
Aandeelprijs
$763.31
Marktkapitalisatie
$53.31B
Verandering (1 dag)
0.87%
Verandering (1 jaar)
8.49%
Land
CH
Handel Lonza Group AG (LONN)
Categorie
Healthcare
EPS voor Lonza Group AG (LONN)
EPS per 2026 TTM: 0
Volgens de laatste financiële rapporten en de aandelenkoers van Lonza Group AG is de huidige EPS van het bedrijf (TTM) 0. Eind 2026 had het bedrijf een EPS van 0, gelijk aan de EPS van 2026 die 0 bedroeg.
EPS-geschiedenis van Lonza Group AG van 2004 tot 2026
EPS aan het einde van elk jaar
| Jaar | EPS | Wijzigen |
|---|---|---|
| 2025 | $-4.95 | -150.09% |
| 2024 | $9.89 | -6.37% |
| 2023 | $10.56 | -40.37% |
| 2022 | $17.71 | -59.29% |
| 2021 | $43.49 | 234.48% |
| 2020 | $13.00 | 44.08% |
| 2019 | $9.02 | 18.21% |
| 2018 | $7.63 | -23.92% |
| 2017 | $10.03 | 78.24% |
| 2016 | $5.63 | 6.18% |
| 2015 | $5.30 | 15.51% |
| 2014 | $4.59 | 145.27% |
| 2013 | $1.87 | -44.92% |
| 2012 | $3.40 | 15.65% |
| 2011 | $2.94 | -46.58% |
| 2010 | $5.50 | 92.65% |
| 2009 | $2.85 | -62.63% |
| 2008 | $7.64 | 47.35% |
| 2007 | $5.18 | 45.65% |
| 2006 | $3.56 | 27.31% |
| 2005 | $2.80 | 17.74% |
| 2004 | $2.37 | 0.00% |
EPS van vergelijkbare bedrijven of concurrenten
| Bedrijf | EPS | EPS-verschil | Land |
|---|---|---|---|
| $17.32 | - |
US
|
|
| $-7.98 | - |
US
|
|
| $-5.29 | - |
AU
|
|
| $27.74 | - |
NL
|
|
| $13.70 | - |
BE
|
